{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:41:17Z","timestamp":1760924477847,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,9,3]],"date-time":"2017-09-03T00:00:00Z","timestamp":1504396800000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004532","name":"Japan International Cooperation Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004532","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Research Partnership for Sustainable Development","award":["08080924"],"award-info":[{"award-number":["08080924"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.biologicals.2016.05.006","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T13:24:58Z","timestamp":1469539498000},"page":"394-402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Recombinant production and characterization of human anti-influenza virus monoclonal antibodies identified from hybridomas fused with human lymphocytes"],"prefix":"10.1016","volume":"44","author":[{"given":"Ryo","family":"Misaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsuko","family":"Fukura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kajiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayo","family":"Yasugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritsuko","family":"Kubota-Koketsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadahiro","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Momota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichiro","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyoshi","family":"Ikuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhito","family":"Fujiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2016.05.006_bib1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.coph.2012.08.001","article-title":"Monoclonal antibody therapeutics: history and future","volume":"12","author":"Buss","year":"2012","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.biologicals.2016.05.006_bib2","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/intimm\/13.12.1551","article-title":"Differences in promiscuity for antibody-FcRn interactions across species: implication for therapeutic antibodies","volume":"13","author":"Ober","year":"2001","journal-title":"Int Immunol"},{"key":"10.1016\/j.biologicals.2016.05.006_bib3","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/321522a0","article-title":"Replacing the complementarity-determining regions in a human antibody with those from a mouse","volume":"321","author":"Jones","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.biologicals.2016.05.006_bib4","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1182\/blood.V66.6.1384.1384","article-title":"Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome","volume":"66","author":"Ogura","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.biologicals.2016.05.006_bib5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.bbrc.2009.06.151","article-title":"Broad neutralizing human monoclonal antibodies against influenza virus from vaccinated healthy donors","volume":"387","author":"Kubota-Koketsu","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.biologicals.2016.05.006_bib6","doi-asserted-by":"crossref","first-page":"e77892","DOI":"10.1371\/journal.pone.0077892","article-title":"Emerging antigenic variants at the antigenic site Sb in pandemic A(H1N1)2009 influenza virus in Japan detected by a human monoclonal antibody","volume":"8","author":"Yasugi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biologicals.2016.05.006_bib7","doi-asserted-by":"crossref","first-page":"e1003150","DOI":"10.1371\/journal.ppat.1003150","article-title":"Human monoclonal antibodies broadly neutralizing against influenza B virus","volume":"9","author":"Yasugi","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.biologicals.2016.05.006_bib8","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nbt0910-917","article-title":"Biopharmaceutical benchmarks","volume":"28","author":"Walsh","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.biologicals.2016.05.006_bib9","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00253-011-3758-5","article-title":"CHO cells in biotechnology for production of recombinant proteins: current state and future potential","volume":"93","author":"Kim","year":"2012","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.biologicals.2016.05.006_bib10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/glycob\/3.2.97","article-title":"Biological roles of oligosaccharides: all of the theories are correct","volume":"3","author":"Varki","year":"1993","journal-title":"Glycobiology"},{"key":"10.1016\/j.biologicals.2016.05.006_bib11","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1126\/science.291.5512.2364","article-title":"Intracellular function of N-linked glycans","volume":"291","author":"Helenius","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.biologicals.2016.05.006_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/oxfordjournals.jbchem.a124721","article-title":"Immunogenicity of N-glycolylneuraminic acid-containing carbohydrate chains of recombinant human erythropoietin expressed in Chinese hamster ovary cells","volume":"117","author":"Noguchi","year":"1995","journal-title":"J\u00a0Biochem"},{"key":"10.1016\/j.biologicals.2016.05.006_bib13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1600-065X.1994.tb00877.x","article-title":"Gal\u03b1(1,3)Gal, the major xenoantigen(s) recognized in pigs by human natural antibodies","volume":"141","author":"Sandrin","year":"1994","journal-title":"Immunol Rev"},{"key":"10.1016\/j.biologicals.2016.05.006_bib14","doi-asserted-by":"crossref","first-page":"11451","DOI":"10.1074\/jbc.275.15.11451","article-title":"\u03b2(1,2)-Xylose and \u03b1(1,3)-fucose residues have a strong contribution in IgE binding to plant glycoallergens","volume":"275","author":"van Ree","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biologicals.2016.05.006_bib15","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/glycob\/cwp079","article-title":"Optimal and consistent protein glycosylation in mammalian cell culture","volume":"19","author":"Hossler","year":"2009","journal-title":"Glycobiology"},{"key":"10.1016\/j.biologicals.2016.05.006_bib16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0008-6215(01)00113-6","article-title":"Rapid and simple preparation of N-linked oligosaccharides by cellulose-column chromatography","volume":"332","author":"Shimizu","year":"2001","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.biologicals.2016.05.006_bib17","first-page":"2169","article-title":"Improved method for fluorescence labeling of sugar chains with sialic acid residues","volume":"54","author":"Kondo","year":"1990","journal-title":"Agric Biol Chem"},{"key":"10.1016\/j.biologicals.2016.05.006_bib18","doi-asserted-by":"crossref","first-page":"26733","DOI":"10.1074\/jbc.M202069200","article-title":"Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity","volume":"277","author":"Shield","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biologicals.2016.05.006_bib19","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1074\/jbc.M210665200","article-title":"The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity","volume":"278","author":"Shinkawa","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biologicals.2016.05.006_bib20","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/glycob\/10.5.477","article-title":"Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics","volume":"10","author":"Raju","year":"2000","journal-title":"Glycobiology"},{"key":"10.1016\/j.biologicals.2016.05.006_bib21","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.nbt.2012.12.002","article-title":"The impact of cell adaptation to serum-free conditions on the glycosylation profile of a monoclonal antibody produced by Chinese hamster ovary cells","volume":"30","author":"Costa","year":"2013","journal-title":"New Biotechnol"},{"key":"10.1016\/j.biologicals.2016.05.006_bib22","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.molimm.2006.09.005","article-title":"Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality","volume":"44","author":"Scallon","year":"2007","journal-title":"Mol Immunol"},{"key":"10.1016\/j.biologicals.2016.05.006_bib23","doi-asserted-by":"crossref","first-page":"e0132848","DOI":"10.1371\/journal.pone.0132848","article-title":"Glycoengineered monoclonal antibodies with homogenous glycan (M3, G0, G2, and A2) using a chemoenzymatic approach have different affinities for Fc\u03b3RIIIa and variable antibody-dependent cellular cytotoxicity activities","volume":"10","author":"Kurogochi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biologicals.2016.05.006_bib24","doi-asserted-by":"crossref","first-page":"e0134949","DOI":"10.1371\/journal.pone.0134949","article-title":"In\u00a0vitro glycoengineering of IgG1 and its effect on Fc receptor binding and ADCC activity","volume":"10","author":"Thomann","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biologicals.2016.05.006_bib25","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1172\/JCI82695","article-title":"Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity","volume":"125","author":"Quast","year":"2015","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.biologicals.2016.05.006_bib26","doi-asserted-by":"crossref","first-page":"e0124677","DOI":"10.1371\/journal.pone.0124677","article-title":"A\u00a0human anti-M2 antibody mediates antibody-dependent cell-mediated cytotoxicity (ADCC) and cytokine secretion by resting and cytokine-preactivated natural killer (NK) cells","volume":"10","author":"Shimhadri","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biologicals.2016.05.006_bib27","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/infdis\/jiv181","article-title":"High antibody-dependent cellular cytotoxicity antibody titers to H5N1 and H7N9 avian influenza A viruses in healthy US adults and older children","volume":"212","author":"Terajima","year":"2015","journal-title":"J\u00a0Infect Dis"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105616300318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105616300318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:13:08Z","timestamp":1760922788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105616300318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S1045105616300318"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2016.05.006","relation":{},"ISSN":["1045-1056"],"issn-type":[{"type":"print","value":"1045-1056"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant production and characterization of human anti-influenza virus monoclonal antibodies identified from hybridomas fused with human lymphocytes","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2016.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}